Hormone replacement therapy in TPOAb-negative pregnant women with subclinical hypothyroidism

2018-11-27
Leonard Wartofsky

Is there ever a need for hormone replacement therapy with levothyroxine in thyroid peroxidase antibody (TPOAb)-negative pregnant women with subclinical hypothyroidism?

Leonard Wartofsky, MD: If there is subclinical hypothyroidism—again, normal thyroxine (T4) and triiodothyronine (T3) but a slightly elevated thyroid-stimulating hormone (TSH) [see Diagnosis of subclinical hypothyroidism in pregnancy]—even in a TPOAb-negative patient, I would start thyroxine therapy for the benefit of the pregnancy.

With subclinical hypothyroidism there is a greater risk of miscarriage and for outcome of pregnancy that justifies the very small risk of thyroxine therapy, if any.

We would love to hear from you

  • Do you have any comments?
  • Have you found a mistake?
  • Would you like to suggest a feature?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.